Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Peiyuan Huayu Formula is a Traditional Chinese Medicine (TCM) herbal decoction developed by the Affiliated Hospital of Shaanxi University of Chinese Medicine. It is specifically formulated for the treatment of chronic subdural hematoma (CSDH), a condition characterized by the accumulation of blood in the subdural space, often following minor head trauma in elderly patients. The formula is based on the TCM therapeutic principles of "Peiyuan" (tonifying the kidney and replenishing the essence) and "Huayu" (activating blood circulation to dissipate blood stasis). It is investigated as a non-surgical intervention or an adjuvant to burr-hole drainage to facilitate hematoma absorption, reduce local inflammation, and decrease the rate of recurrence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Peiyuan Huayu Formula.